[PTX] YoY Quarter Result on 31-Dec-2017 [#Q2]

Stock
[PTX] Prescient Therapeutics Limited
Announcement Date
30-Dec-2017
Financial Year
2018
Quarter
31-Dec-2017 [#Q2]
Profit Trend
QoQ- 23.58%
YoY- -15.23%
Quarter Report
PTX's Result
PTX's Financial Summary
View:
Show?
Quarter Result
31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 CAGR
Revenue 648 599 711 457 563 712 31 65.89%
PBT -2,396 -2,296 -1,594 -1,180 -1,024 -623 -1,063 14.49%
Tax -598 -599 0 0 0 47 -12 91.71%
NP -1,798 -1,697 -1,594 -1,180 -1,024 -623 -1,063 9.14%
Tax Rate - - - - - - - -
Total Cost 2,446 2,296 2,305 1,637 1,588 1,335 1,094 14.33%
Ratio Analysis
31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 CAGR
NP Margin -277.59 -283.28 -224.38 -258.42 -181.76 -87.46 -3,413.87 -34.15%
Per Share
31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 CAGR
EPS -0.00 -0.00 -0.01 -0.01 -0.00 -0.01 -0.02 -
EPS Diluted -0.00 -0.00 -0.01 -0.01 -0.00 -0.01 -0.02 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.